World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
128
Citations
54975
World Ranking
2735
National Ranking
1528

Overview

Harry W. Herr is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on medicine with significant contributions in surgery, urology, molecular biology, epidemiology, and oncology. The main areas of study concentrate on bladder and urothelial cancer treatments, urinary and genital oncology studies, urological disorders and treatments, epigenetics and DNA methylation, urinary bladder and prostate research, pediatric urology and nephrology studies, and cancer immunotherapy and biomarkers.

The scientist has published extensively in several venues, with the highest number of publications appearing in The Journal of Urology, followed by the Journal of Clinical Oncology, Urology, Urologic Oncology Seminars and Original Investigations, and the Journal of the National Comprehensive Cancer Network.

Frequent coauthors collaborating with Harry W. Herr include Bernard H. Bochner, S. Machele Donat, Guido Dalbagni, Eugene J. Pietzak, and K. Eugene, reflecting a network of professionals working in related fields.

Some of the recent papers authored or coauthored by Harry W. Herr include:

  • Bladder Cancer, Version 3.2020, published in 2020 in the Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022, published in 2022 in the Journal of the National Comprehensive Cancer Network
  • Bladder Cancer, Version 3.2024, published in 2024 in the Journal of the National Comprehensive Cancer Network
  • Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial, published in 2022 in the Journal of Clinical Oncology
  • Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma, published in 2023 in the Journal of Clinical Oncology

Best Publications

  • Epidemiology and risk factors of urothelial bladder cancer

    Maximilian Burger;James W.F. Catto;Guido Dalbagni;H. Barton Grossman

  • Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

    Ahmad Shabsigh;Ruslan Korets;Kinjal C. Vora;Christine M. Brooks

  • Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

    Donald L. Lamm;Ad P.M. Van Der Meijden;Alvaro Morales;Stanley A. Brosman

  • Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.

    Harry W. Herr;Bernard H. Bochner;Guido Dalbagni;S. Machele Donat

  • Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.

    Cora N. Sternberg;Alan Yagoda;Howard I. Scher;Robin C. Watson

  • Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy

    Dean F. Bajorin;Paul M. Dodd;Madhu Mazumdar;Melissa Fazzari

  • The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year Outcome

    Michael S. Cookson;Harry W. Herr;Zuo Feng Zhang;Scott Soloway

  • Surgical Factors Influence Bladder Cancer Outcomes: A Cooperative Group Report

    Harry W. Herr;James R. Faulkner;H. Barton Grossman;Ronald B. Natale

  • Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease Progression

    Alvaro S. Sarkis;Guido Dalbagni;Carlos Cordon-Cardo;Zuo-Feng Zhang

  • THE VALUE OF A SECOND TRANSURETHRAL RESECTION IN EVALUATING PATIENTS WITH BLADDER TUMORS

    Harry W. Herr

  • Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

    Bernard H. Bochner;Guido Dalbagni;Daniel D. Sjoberg;Jonathan Silberstein;Jonathan Silberstein

  • CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

    Padmanee Sharma;Yu Shen;Sijin Wen;Sachiko Yamada

  • M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

    Cora N. Sternberg;Cora N. Sternberg;Alan Yagoda;Alan Yagoda;Howard I. Scher;Howard I. Scher;Robin C. Watson;Robin C. Watson

  • DOES EARLY CYSTECTOMY IMPROVE THE SURVIVAL OF PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER TUMORS

    Harry W. Herr;Pramod C. Sogani

  • PARTIAL NEPHRECTOMY FOR UNILATERAL RENAL CARCINOMA AND A NORMAL CONTRALATERAL KIDNEY: 10-YEAR FOLLOWUP

    Harry W. Herr

  • Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care.

    Alice B. Kornblith;Harry W. Herr;Ursula S. Ofman;Howard I. Scher

  • Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

    D F Bajorin;M F Sarosdy;D G Pfister;M Mazumdar

  • Bladder cancer. Clinical practice guidelines in oncology.

    Peter E. Clark;Neeraj Agarwal;Matthew C. Biagioli;Mario A. Eisenberger

  • Superiority of Ratio Based Lymph Node Staging for Bladder Cancer

    Harry W. Herr

  • History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story

    Harry W. Herr;Alvaro Morales

Frequent Co-Authors

Guido Dalbagni
Guido Dalbagni Memorial Sloan Kettering Cancer Center
Bernard H. Bochner
Bernard H. Bochner Memorial Sloan Kettering Cancer Center
Willet F. Whitmore
Willet F. Whitmore Memorial Sloan Kettering Cancer Center
Dean F. Bajorin
Dean F. Bajorin Memorial Sloan Kettering Cancer Center
William R. Fair
William R. Fair Memorial Sloan Kettering Cancer Center
Victor E. Reuter
Victor E. Reuter Memorial Sloan Kettering Cancer Center
Paul Russo
Paul Russo Memorial Sloan Kettering Cancer Center
Jonathan E. Rosenberg
Jonathan E. Rosenberg Memorial Sloan Kettering Cancer Center
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Hikmat Al-Ahmadie
Hikmat Al-Ahmadie Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine in the USA isn't limited to traditional medical school. Numerous affordable online programs now allow students to enter healthcare roles or advance their education, often while working or balancing other commitments. For those beginning their journey, the cheapest online bsn programs provide a flexible route to earning a Bachelor of Science in Nursing, which is the foundation required for many clinical jobs.

Registered nurses seeking to expand their qualifications may consider the rn to bsn online pathway. This is designed specifically for working RNs needing an affordable and convenient way to obtain a BSN. Similarly, nurses aiming for leadership roles or advanced clinical positions can look into the cheapest online np programs, which train nurse practitioners who play a critical role in modern healthcare.

For those interested in research, teaching, or executive-level leadership, the cheapest phd nursing programs make it possible to earn a doctorate online. Exploring these online degree options is a smart step for anyone considering the many dynamic career pathways related to medicine in the USA.

Best Scientists Citing Harry W. Herr

Trending Scientists

Recently Published Articles